Premium
What Should We Expect From a Bioartificial Liver In Fulminant Hepatic Failure?
Author(s) -
Bismuth Henri,
Figueiro Jose,
Samuel Didier
Publication year - 1998
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1046/j.1525-1594.1998.06059.x
Subject(s) - bioartificial liver device , fulminant hepatic failure , economic shortage , fulminant , liver transplantation , liver failure , medicine , bridge to transplantation , intensive care medicine , transplantation , gastroenterology , chemistry , hepatocyte , heart transplantation , philosophy , biochemistry , linguistics , government (linguistics) , in vitro
Fulminant hepatic failure is associated with high mortality. Liver transplantation is an effective therapy that improves survival, and because of donor organ shortage and urgency, a bioartificial liver could act as an effective bridge to liver transplantation in patients with fulminant hepatic failure. We discuss the place of the bioartificial liver in the treatment of other causes of liver failure.